2026-03-13 - CD Milan - Neurocrine Biosciences v. Spruce Biosciences - UPC_CFI_722/2025
- Aktenzeichen:
- UPC_CFI_722/2025
- Datum:
- Spruchkörper:
- Court of First Instance - Milan (IT) Central Division- Section
- Art:
- Decision
- Parteien:
- Neurocrine Biosciences, Inc. v. Spruce Biosciences, Inc.
Kernaussage: Milan CD disposes of revocation action under R.
2026-03-13 - CD Milan - Neurocrine Biosciences
v.
Spruce Biosciences - UPC_CFI_722/2025
notable
Milan CD disposes of revocation action under R. 360 RoP after the EPO Opposition Division revoked the patent in its entirety (decision became final when patentee declared it would not appeal). Claimant's conditional request (disposal only if defendant undertakes not to enforce divisionals) rejected — outside the scope of R. 360. The patent's revocation does not mean divisionals will share the same fate. Costs allocated to defendant (Spruce) as unsuccessful party: EUR 480,000 (80% of EUR 600,000 ceiling — front-loaded costs already incurred through written phase). Expert costs denied — insufficient detail showing attribution solely to UPC proceedings.